Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Recruiting now · Not applicable

Conditions studied: Diabetes Type 2, Kidney Disease

In brief

This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).

Key facts

Study ID

NCT07485075

Run by

Steno Diabetes Center Copenhagen

People needed

104

Starts

2026-03-20

Expected to finish

2027-12-31

Last updated by the study team

2026-03-20

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes (ICD-10 DE11.x)
• Age 18-74 years
• BMI < 35 kg/m²
• eGFR 30-59 ml/min and UACR > 30 mg/g
• Stable medication for ≥3 months
• Ability to read and understand Danish

You may not qualify if…

• Type 1 diabetes or other diabetes types
• Current vegan diet
• Active cancer
• Short bowel syndrome or celiac disease
• Use of sodium chloride tablets
• No access to digital platform (intervention group only)

Where it is running

• Steno Diabetes Center Copenhagen, — Herlev, Captial Region of Denmark, Denmark (enrolling)
• Nordsjællands Hospital, Hillerød — Hillerød, Captial Region of Denmark, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.